期刊文献+

全基因组测序在结核分枝杆菌研究中的应用 被引量:23

Application of whole genome sequencing in research of Mycobacterium tuberculosis
暂未订购
导出
摘要 全基因组测序技术已经广泛应用于结核分枝杆菌的研究中,包括结核分枝杆菌谱系或亚种鉴定、区分患者的发病模式,以及识别传染源、超级传播者和确定传播方向,以及用于结核分枝杆菌的耐药性预测和微进化研究等,在临床和公共卫生领域发挥了很重要的作用。即便如此,目前还存在很多问题需要解决。作者对全基因组测序技术在结核分枝杆菌研究中的相关内容、应用成果及进展进行综述。 Whole genome sequencing has been widely used in the research of Mycobacterium tuberculosis(M.tuberculosis),including classification of M.tuberculosis lineages or subspecies,differentiation of disease patterns,identification of putative source cases and super-spreaders,determination of the transmission chains and their directions,as well as prediction of drug resistance of M.tuberculosis and detection of microevolution of M.tuberculosis.Although the whole genome sequencing has played an important role in clinical and public health applications,many problems are still existed and should be resolved in future.Herein,the current research directions and achievements of whole genome sequencing are reviewed,and the future applications are prospected.
作者 张洁 任怡宣 潘丽萍 张宗德 ZHANG Jie;REN Yi-xuan;PAN Li-ping;ZHANG Zong-de(Beijing Key Laboratory of Drug-resistant Tuberculosis Research,Institute of Tuberculosis and Thoracic Tumor,Beijing Chest Hospital,Capital Medical University,Beijing 101149,China;Central Laboratory of Beijing Research Institute for Tuberculosis Control,Beijing 100035,China;不详)
出处 《中国防痨杂志》 CAS CSCD 2020年第7期737-740,共4页 Chinese Journal of Antituberculosis
基金 “十三五”国家科技重大专项(2017ZX10201301004) 北京市医院管理局“登峰”人才培养计划(DFL20181601)。
关键词 分枝杆菌 结核 全基因组关联研究 高通量核苷酸测序 分子诊断技术 综述 Mycobacterium tuberculosis Genome-wide association study High-throughput nucleotide sequencing Molecular diagnostic techniques Review
  • 相关文献

参考文献2

二级参考文献24

  • 1唐神结,肖和平.耐多药结核病的综合治疗[J].中华结核和呼吸杂志,2003,26(11):715-718. 被引量:65
  • 2端木宏谨.耐药结核病的流行和监测[J].中华结核和呼吸杂志,2006,29(8):509-511. 被引量:38
  • 3World Health Organization. Global tuberculosis report 2012 [ R ] . Geneva: WHO, 2012.
  • 4World Health Organization. Muhidrug and extensively drug-resistant TB (M/XDR- TB): 2010 global report on surveillance and response[ R]. Geneva: WHO, 2010.
  • 5World Health Organization. Treatment of tuberculosis: guidelines [ R ] . Geneva: WHO, 2010.
  • 6Almeida Da Silva PE, Palomino JC. Molecular basis and mechanisms of drug resistance in Mycobacterium tuberculosis: classical and new drugs[ J ]. J Antimicrob Chemother, 2011,66: 1417-1430.
  • 7Blakemore R, Story E, Helb D, et al. Evaluation of the analytical performance of the Xpert MTB/RIF assay [ J ]. J Clin Microbiol, 2010, 48: 2495-2501.
  • 8Boehme CC, Nabeta P, Hillemann D, et al. Rapid molecular detection of tuberculosis and rifampin resistance [ J ]. N Engl J Med, 2010, 363: 1005-1015.
  • 9Maruri F, Sterling TR, Kaiga AW, et al. A systematic review of gyrase mutations associated with fluoroquinolone-resistant Mycobacterium tuberculosis and a proposed gyrase numbering system[J]. J Antimicrob Chemother, 2012, 67: 819-831.
  • 10Rinder H, Mieskes KT, Lsscher T. Heteroresistance in Mycobaeterium tuberculosis[ J ]. Int J Tuberc Lung Dis, 2001,5 : 339-345.

共引文献52

同被引文献177

引证文献23

二级引证文献54

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部